SUPPRELIN® LA: Audience

SUPPRELIN® LA is an implanted gonadotropin releasing hormone (GnRH) medicine designed for the treatment of children with central precocious puberty (CPP). It provides a long-term solution by releasing medication for 12 months through a subcutaneous implant.